WAT

WAT

USD

Waters Corporation Common Stock

$350.450+2.030 (0.583%)

Reaalajas hind

Healthcare
Diagnostics & Research
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$348.420

Kõrge

$358.285

Madal

$345.730

Maht

0.10M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

20.9B

Tööstusharu

Diagnostics & Research

Riik

United States

Kauplemisstatistika

Keskmine maht

0.54M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $279.24Praegune $350.450Kõrge $423.56

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 1. mai 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

WAT: Waters Corporation Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: WAT Generate Date: 2025-05-01 15:16:13

Okay, let's break down what's been going on with Waters Corporation stock lately. We'll look at the recent news, how the price has been acting, and what some of the automated tools are suggesting.

Recent News Buzz: What Are People Saying?

The main chatter around Waters recently involves analysts adjusting their views. We saw two separate reports from big firms, Baird and Barclays, in April. Both of them kept their overall rating on the stock (Baird says "Outperform," Barclays says "Equal-Weight"), but here's the key part: they both lowered their price targets.

Think of a price target as what an analyst thinks the stock should be worth in the future. Baird dropped their target from $407 down to $355, and Barclays cut theirs from $400 to $350. When analysts lower these targets, it usually signals they see less potential for the stock to climb as high as they previously thought. So, this news leans a bit negative, showing some caution from the pros.

On a different note, the company has scheduled its first-quarter earnings call for May 6th. This is a big deal because it's when Waters will tell everyone how they performed financially over the last few months. Earnings reports can often cause the stock price to move quite a bit, depending on whether the results are better or worse than expected. It's a key event coming up very soon.

Price Check: What's the Stock Price Been Doing?

Looking at the price chart over the last three months or so, it's been a bit of a rollercoaster, but mostly heading downhill for a while. Back in early February, the stock was trading up around the $400-$415 mark. From there, it saw a pretty significant drop through March and into April, hitting lows down around $300-$310 in mid-April.

More recently, though, the price seems to have found some footing and bounced back a bit. The last recorded price point we have, for May 1st, is around $346. This is well below those February highs but a decent recovery from the April lows. The trading volume has also been quite varied, with some days seeing much higher activity, especially during the sharper drops and bounces in April.

Interestingly, an AI prediction model is forecasting some upward movement in the very short term. It's calling for a gain of nearly 2% today (May 1st), over 2.5% tomorrow, and almost 4% the day after. This suggests the AI sees potential for the recent bounce to continue for a few days.

Putting It Together: Outlook & Ideas

So, we have a mixed bag here. Analysts are trimming their expectations (negative signal), but the stock price has already taken a big hit and is showing signs of bouncing back from its lows. Plus, the AI model is predicting short-term gains. The big unknown is that earnings report coming up next week.

Based on the recent price bounce and the AI's short-term bullish prediction, the apparent near-term leaning seems cautiously positive, especially heading into the earnings report. The market might be anticipating decent results, or perhaps the stock was simply oversold after its earlier decline.

If you were considering this stock based on this data, and leaning towards the AI's short-term view, a potential entry consideration might be around the current price level (around $345-$348). This area aligns with where the stock has recently stabilized and bounced, and it's within the entry range suggested by some recommendation data ($345.52 - $348.24).

For managing risk, a potential exit or stop-loss consideration could be placed below the recent lows. The recommendation data suggests a stop-loss at $312.95. This level is well below the recent bounce area and would signal that the upward momentum has failed and the downtrend might be resuming. On the upside, if the stock does climb, the recommendation data points to a potential take-profit level around $371.99. This would represent a solid gain from the current price and could be a level to watch for potential resistance or to lock in profits.

Remember, these are just potential ideas based on the provided data and AI predictions. The earnings report on May 6th is a major wildcard that could send the stock in either direction very quickly.

Company Context

Just a quick reminder about Waters Corporation itself: they are a healthcare company focused on Diagnostics & Research, specifically making analytical instruments like those used in labs for drug discovery, testing, and quality control. Their business depends heavily on spending by pharmaceutical companies, research institutions, and other industries needing precise analysis. Analyst views and earnings reports are particularly important for a company like this, as they give insight into demand for their specialized equipment. Also worth noting from the data, the company has a relatively high debt level compared to its equity, which is something to keep in mind, although it also boasts a very high return on equity.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.

Seotud uudised

Analyst Upgrades

Baird Maintains Outperform on Waters, Lowers Price Target to $355

Baird analyst Catherine Ramsey maintains Waters with a Outperform and lowers the price target from $407 to $355.

Vaata rohkem
Baird Maintains Outperform on Waters, Lowers Price Target to $355
Analyst Upgrades

Barclays Maintains Equal-Weight on Waters, Lowers Price Target to $350

Barclays analyst Luke Sergott maintains Waters with a Equal-Weight and lowers the price target from $400 to $350.

Vaata rohkem
Barclays Maintains Equal-Weight on Waters, Lowers Price Target to $350
PR Newswire

Waters Corporation Schedules First Quarter 2025 Earnings Conference Call

Waters Corporation (NYSE:WAT) will hold its Q1 2025 financial results conference call on Tuesday, May 6th, 2025 at 8:00 a.m. Eastern Time. A live...

Vaata rohkem
Waters Corporation Schedules First Quarter 2025 Earnings Conference Call

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 3. mai 2025, 12:19

LangevNeutraalneTõusev

71.3% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Konservatiivne
Kauplemisjuhend

Sisenemispunkt

$351.20

Võta kasum

$357.52

Peata kahjum

$315.46

Põhitegurid

DMI näitab langustrendi (ADX:14.7, +DI:7.9, -DI:8.9), mis viitab ettevaatlikkusele
Praegune hind on tugitasemele ($350.58) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 10.7x keskmisest (5,977), mis viitab äärmiselt tugevale ostusurvele
MACD 0.2562 on signaalijoone 0.2130 kohal, mis viitab tõusvale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.